Intervention Review

You have free access to this content

Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care

  1. Roberto D'Amico1,*,
  2. Silvia Pifferi2,
  3. Valter Torri3,
  4. Luca Brazzi4,
  5. Elena Parmelli5,
  6. Alessandro Liberati6,†

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 13 MAR 2009

DOI: 10.1002/14651858.CD000022.pub3


How to Cite

D'Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E, Liberati A. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD000022. DOI: 10.1002/14651858.CD000022.pub3.

Author Information

  1. 1

    University of Modena and Reggio Emilia, Statistics Unit, Department of clinical and diagnostic medicine and public health, University of Modena and Reggio Emilia, Modena, Italy, Modena, Italy

  2. 2

    Policlinico San Matteo, Pavia, Milano, Italy

  3. 3

    Mario Negri Institute, Laboratorio di Epidemiologia Clinica, Milano, Milano, Italy

  4. 4

    Università degli Studi di Sassari, Dipartimento di Scienze Chirurgiche, Microchirurgiche e Mediche, Sassari, Italy

  5. 5

    University of Modena and Reggio Emilia, Department of Oncology, Hematology and Respiratory Diseases, Modena, Italy

  6. 6

    Mario Negri Institute for Pharmacological Research, Italian Cochrane Centre, Milan, Italy

  1. Deceased

*Roberto D'Amico, Statistics Unit, Department of clinical and diagnostic medicine and public health, University of Modena and Reggio Emilia, Modena, Italy, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41121, Italy. roberto.damico@unimore.it.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

[Figure 1]
Figure 1.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 1 Overall mortality.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 2 Mortality according to quality of allocation concealment.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 3 Mortality according to blinding of the studies.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 4 RTIs.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 5 RTIs according to quality of allocation concealment.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Topical plus systemic versus no prophylaxis, Outcome 6 RTIs according to blinding of the studies.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Topical versus control, Outcome 1 Overall mortality.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Topical versus control, Outcome 2 Mortality according to quality of allocation concealment.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Topical versus control, Outcome 3 Mortality according to blinding of the studies.
[Analysis 2.4]
Analysis 2.4. Comparison 2 Topical versus control, Outcome 4 RTIs.
[Analysis 2.5]
Analysis 2.5. Comparison 2 Topical versus control, Outcome 5 RTIs according to quality of allocation concealment.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Topical versus control, Outcome 6 RTIs according to blinding of the studies.